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Antibody-coated bacteria in persistent and recurrent urinary
tract infections. Multiple urine specimens from 24 patients (16
with pyelonephritis; 8 with cystitis) were tested over a period of
time ranging from 2 months to over 3 years to determine whether
the results of the urine fluorescent antibody (FA) test changed
with persistent or recurrent infection. These 24 patients, who
were a part of our initially reported study of antibody-coated
bacteria, had returned to the clinic because of continued prob-
lems with infection. The FA test results remained positive for 12
patients who had persistent or recurrent kidney infections in-
volving the same bacterial strain. Five other patients had recur-
rences caused by strains different from the bacterial isolate in-
volved in the previous kidney infection; these 5 patients had a
total of 27 reinfection episodes, and 13 of the episodes were asso-
ciated with negative FA tests. Direct localization studies showed
that, in the course of persisting infection, changes in the FA test
results from negative to positive were associated with the ascen-
dence of infection to the kidney. Unbound (excess, free) anti-
bacterial antibody detected in the urines from 12 of 14 patients
with renal infection was found to be weakly cross reactive with
bacteria other than the one causing the infection; this antibody
persisted with continued infection, although it was short-lived
after the infection had subsided, disappearing by the 4th month.
FA test results were consistently negative for 8 patients with re-
current episodes of cystitis but without past history or evidence
of pyelonephritis.
Batteries recouvertes d'anticorps dans les infections urinaries
persistantes et récidivantes. Dc nombreux échantillons d'urine de
24 malades (16 atteints de pyélonéphnte et 8 de cystite) ont été
étudiés sur une pénode allant de 2 mois a plus de 3 ans, pour
savoir Si les résultats de Ia recherche d'anticorps fluorescents
(FA) sont modifies par l'infection persistante ou rCcidivante. Ces
24 malades, qui faisaient partie de notre étude anterieure sur les
bactéries recouvertes d'anticorps, sont revenus consulter en rai-
son de Ia persistance de problemes d'infection. Le test FA est
resté positif pour 12 malades qui avaient des infections rCnales
persistantes ou rCcidivantes impliquant Ia méme souche bactC-
rienne. Cinq autres malades ont eu des rCcidives dCterminCes
par une souche différente de celle isolCe au cours de l'infection
rCnale antCrieure. Ces 5 malades ont eu au total 27 episodes de
re-infection et Ic test FA a etC nCgatif dans 13 de ces episodes.
Les etudes de localisation directe montrent que, au cours des
infections persistantes, des modifications des rCsultats du test
FA du negatif au positif sont associCes a l'ascension de
l'infection jusqu'au rein. L'anticorps anti-bactCrien non lie
(libre, en excès) dCtectC dans les urines de 12 parmi les 14 mat-
ades atteints d'infection rCnale est faiblement réactif avec des
bactCries différentes de celle responsable de I'infection. Cet anti-
corps persiste lors d'infections persistantes, alors que sa prC-
sence aprCs Ia disparition de l'infection n'est pas supCneure a 4
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mois. Les rCsultats du test FA ont ete constamment negatifs
pour 8 malades atteints de cystite rCcidivante mais sans antCcCd-
ents ni de signes de pyelonephrite.
In 1974 we reported that a simple, noninvasive
test is useful in distinguishing kidney infection from
bladder infection [1]. The procedure uses immuno-
fluorescence to detect antibody-coated bacteria in
clean-catch midstream urine specimens from pa-
tients with pyelonephritis; the test is negative with
urine specimens from patients with cystitis, but
may be positive with prostatitis. Our further stud-
ies, as well as those of others, have confirmed our
initial findings [2—9]. The early observations were
made on a group of 60 patients: 34 with chronic py-
elonephritis, 1 with acute pyelonephritis, 20 with
cystitis, and 5 with prostatitis. We were able to fol-
low 24 of the 60 patients—some for as long as 3 '/
years—with repeated testing of urine specimens for
the presence of antibody-coated bacteria. The fol-
low-up study provided answers to questions that we
had asked from the beginning: What happens to the
results of the fluorescent antibody (FA) test in the
course of persistent infection or recurrence of infec-
tion with the same organism or with a different orga-
nism? In this regard, is there a difference between
kidney and bladder infections? Is unbound (excess
or free) antimicrobial antibody present in a urine
sample that contains antibody-coated bacteria? Can
the unbound urinary antibody cross react with bac-
teria which are present in urine but which did not
cause the kidney infection?
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Methods
Diagnosis. We continued to collect urine speci-
mens from 24 (20 females and 4 males) of the 60
patients who participated in our initial study [1] and
who remained available for follow-up study. These
individuals were not selected by us, but were those
patients whose chronic or recurrent problems
brought them back to our clinic. Patients were fol-
lowed at 2-week to 2-month intervals, depending on
their stage of treatment and clinical status. Of the 24
patients, 16 had persisting or recurrent renal infec-
tion and 8 had recurrent cystitis. The diagnosis of
chronic pyelonephritis was based on a patient's
clinical course, characteristic changes on i.v. py-
elography, impairment in renal function, results of
urine cultures, and direct localization when pos-
sible. Creatinine values were normal for 7 of the 16
patients, but for 9 patients were definitely elevated
(>2.0 mgldl). Direct localization of the site of infec-
tion by ureteral catheterization or the bladder wash-
out method [10] substantiated the renal origin of the
bacteriuria in one episode for each of 6 patients and
in two episodes for a 7th patient. In 3 other patients,
the clinical diagnosis of pyelonephritis was support-
ed by microscopic examination of nephrectomy
specimens which revealed chronic interstitial ne-
phritis accompanied by lymphoid cell infiltration in
subepithelial areas of the catyces. Of the 15 patients
tested, 11 had elevated serum antibody titers (
512) against their own infecting organism as deter-
mined by indirect FA testing.
Cystitis was diagnosed on the basis of lower uri-
nary tract symptoms in the absence of fever, costo-
vertebral-angle tenderness, and demonstration of
significant bacteriuria (bacteria count,  100,000/
ml) by at least two cultures. The diagnosis for all 8
patients was substantiated by the absence of radio-
graphic changes suggestive of pyelonephritis on i.v.
pyelography. Renal concentrating ability was nor-
mal after 14 hours of water deprivation in the 4 pa-
tients studied, the value (± so) being 924 81
mOsm/kg. The serum antibody titer against the pa-
tient's own infecting organism was within the nor-
mal range for each of these 8 patients.
Cultures. The urine specimens were cultured
quantitatively by the calibrated ioop technique, and
the bacterial isolates were identified by standard
bacteriologic and biochemical procedures. E. coli
isolates were serologically grouped according to the
0 antigen and serologically typed according to the H
antigen.
Direct irninunofluorescence test. The urine speci-
mens were tested for the presence of antibody-
coated bacteria as previously reported [1, 3] by di-
rect fluorescent antibody (FA) testing using fluores-
cein-conjugated antihuman globulin of horse origin
(Roboz Surgical Instrument Company, Washing-
ton, D.C.). Tests were recorded as negative, bor-
derline positive, or positive [3, 41. A control was set
up with each FA test to confirm that the fluorescein-
conjugated antiserum was free of antibody against
the patient's subcultured urinary pathogen [11.
Indirect immunofluorescence test. Serum anti-
body titers against the patient's own infecting bac-
teria were determined by indirect FA testing [11; sa-
line controls and normal human serum controls
were included in each test. To determine whether
free (excess or unbound) antibody reactive with the
infecting bacteria was present in the urines known
to contain antibody-coated bacteria, multiple urine
specimens from 14 of the 16 patients with renal in-
fection were tested by indirect immunofluores-
cence. The FA procedure was previously described
[1], except in these tests we used undiluted urine
rather than dilutions of serum. Saline controls and
normal human urine controls were included in each
test. In addition, indirect FA studies were included
to determine whether the unbound antimicrobial
antibody in the urine supernatant would cross react
with subcultured laboratory strains of urinary tract
pathogens other than the one that caused the infec-
tion.
Results
Direct fluorescent antibody test for detection of
antibody-coated bacteria in urine. Urine specimens
were collected over periods ranging from 2 months
to 31/2 years from 16 patients with persistent and
recurrent renal infection. Eight of the patients
(Table 1 ,A) had persistent infections with the same
bacterial strains, despite intermittent courses of
antimicrobial therapy. The FA tests for the pres-
ence of antibody-coated bacteria remained positive
with each sampling. Seven of the eight patients had
elevated serum antibody titers ( 512) against their
own infecting organisms, as determined by indirect
FA-testing.
Urine cultures for 4 of the 16 patients with renal
infections (Table I ,B) became negative after the pa-
tients were treated; in each case, however, infec-
tion caused by the same bacterial strain recurred
within 2 months of treatment. With each recur-
rence, the FA test remained positive. Antibody ti-
ters against the patient's own infecting organism
were elevated in serum specimens from the 3 pa-
tients tested.
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Table 1. Persistent and recurrent renal parenchymal infection: Results of FA tests on multiple urine specimens from 12 patients
Diagnosis
Duration of infection, months
Direct localization method confirming kidney infection
Urine specimensa




A. Persistent renal infection:
1. Female, contracted right kidney (30) 14/14 Klebsie/la pneumoniae 1024
Ureteral catheterization
2. Female, contracted right kidney (2) 3/3 K. pneumoniae 2048
Ureteral catheterization
3. Female, hypoplastic kidneys (5) 2/2 K. pneumoniae 32
Tissue examination
4. Male, renal calculi (8) 5/5 K. pneumoniae 1024
Tissue examination
5. Female, renal calculi (4) 2/2 Pseudomonas aeruginosa 2048
Ureteral catheterization
6. Male, renal calculi (11) 5/5 P. aeruginosa 2048
Ureteral catheterization
7. Female, contracted right kidney (4) 2/2 K. pneumoniae
Escherichia co/i 06, NMC
512
4096
8. Female, asymptomatic bactenuria (Ii) 5/5 E. co/i 04, NM 4096
B. Recurring episodes of renal infection caused by the same bacteriad:
9. Female, renal scarring (2) 2/2 E. coli NT NIY
10. Female, advanced renal insufficiency (14) 5/5 E. co/i 018, NM 1024
11. Female, diabetes mellitus, papillary necrosis (37) 29/29 Citrobacter diversus 1024
Ureteral catheterization
12.1. Female, renal calculi (3) 2/2 K. pneumoniae 40%
12,2. Female, renal calculi (26) 13/13 P. aeruginosa 512
aDuring the period of attendance at clinic, multiple urine specimens were collected from patients with persistent and recurrent renal
infections; urine specimens were tested by FA for the presence of antibody-coated bacteria.
"This was done by indirect fluorescent antibody method with results expressed as reciprocal of serum dilution endpoint.
CNM is nonmotile; NT, nontypable; and ND, not done.
dFour patients whose renal infections recurred after cultures became negative with therapy; specimens were FA positive before and
after each recurrence: patient 9, one episode; patient 10, three episodes; patient 11, two episodes.
ej patient 12.2 the P. aeruginosa reinfection lasted 4 months; the infection cleared with therapy but recurred within 2 months and
persisted for another 20 months.
One of the patients (Table I ,B, no. 12) and the
remaining 4 of the 16 patients with pyelonephritis
(Table 2) had multiple recurring episodes of urinary
tract infections caused by bacterial strains other
than those initially isolated; these reinfections oc-
cuffed after the patients had been treated and after
a period during which urine cultures were negative.
These 5 patients experienced 27 reinfection epi-
sodes; the FA tests were positive in 14 reinfections
and negative in 13. Patient 12 (Table I ,B) had a
Kiebsiella infection for 3 months and was then in-
fected with Pseudomonas aeruginosa. The initial
Pseudomonas infection lasted for 4 months; it re-
cuffed within 2 months after therapy and persisted
for 20 months. The FA tests were positive with each
recurnng episode. The other 4 patients (Table 2)
had a total of 26 reinfection episodes. FA tests were
positive during 13 episodes; follow-up specimens
from this group of patients continued to be FA-posi-
tive. The other 13 reinfection episodes were associ-
ated with negative FA tests; for 3 patients, how-
ever, the FA test results changed to positive during
persistent infection with the same bacterial strain
during 5 of the 13 reinfection episodes. Our esti-
mates of conversion time were based on the dura-
tion of infection for each patient; this time varied
from patient to patient, ranging from 6 to 16 weeks
(mean of 10 weeks). Two direct localization studies
by the bladder washout method on I of the 3 pa-
tients (patient no. 15) were made after the FA test
had changed to positive during two separate rein-
fections; the results indicated that the bacteria came
from the kidney during each of the two episodes.
Multiple urine specimens from the 8 patients with
cystitis were also tested to determine whether the
results of FA tests changed with recurrence of in-
fection. The FA tests remained negative during and
after each episode of recurrent cystitis in these pa-
tients. One patient had ten episodes of cystitis. Af-
ter the initial infection with E. co/i 018, she had
three reinfections, each caused by a different micro-
organism. The third reinfection, due to Kiebsiella
pneumoniae, was followed by two recurrences
caused by this organism. Then an E. coli 06 reinfec-
tion was followed by three Kiebsiella infections.
With each recurrence, the FA test remained nega-
tive. The other 7 patients with cystitis had similar
episodes of recurring infections during which the
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Table 2. Results of FA tests on urine specimens from four patients with pyelonephritis who had multiple recurrences of urinary tract
infections caused by bacterial strains other than the initial isolate
Initial kidney infection
—- Recurrent urinary tract infection
Diagnosis
FA test for
presence of Reinfection Positive Negative
Direct localization method antibody-coated episodes urine FA test urine FA test
confirming kidney infection bacteria (26) (13) (13)
13. Female, diabetes mellitus Pos 4 2 2(1)a
Bladder washout
14. Male, renal calculi Pos 4 3 1
Tissue examination
15. Female, contracted right kidney Pos 5 0 5 (2)
Bladder washout
16. Female, diabetes mellitus Pos 13 8 5 (2)a
aNumbers in parentheses indicate positive FA tests on follow-up urine specimens collected during five reinfection episodes involving
three of the four patients; estimates of conversion times ranged from 6 to 16 weeks.
urine FA tests remained negative; 5 patients had re-
currences involving the same bacterial strains and 2
had recurrences caused by bacteria other than the
initial isolates. Each of the 8 patients with cystitis
had a low serum antibody titer ( 128) against her
own infecting microorganism.
Indirect fluorescent antibody (IFA) test for detec-
tion of free antibody in urine. We used indirect im-
munofluorescence to determine whether free (ex-
cess or unbound) antibody reactive with the infect-
ing bacteria was present in the urine samples known
to contain antibody-coated bacteria. Supernatants
from multiple urine specimens from 14 of the 16 pa-
tients with persisting or recurring renal infections
were incubated with subcultures of the patient's
own bacterial isolates; after incubation and wash-
ing, the bacterial sediment was incubated with fluo-
rescein-conjugated antihuman globulin and washed
again; smears were prepared and examined micro-
scopically for fluorescence. Specimens from 7 of
the 14 patients contained free antibody that reacted
with the patient's own subcultured bacteria (pa-
tients 2, 5, 8, 10, Il, 13, 14; Tables 1 and 2); free
antimicrobial antibody was also present in each of
40 follow-up specimens collected from these 7 pa-
tients during periods of persisting infection with the
same bacterial strains. The other 7 patients with
persistent or recurrent infections did not initially
have free antibody in their urine specimens, but it
became detectable within 4 months (range, I to 16
weeks) in the follow-up specimens from 5 of the pa-
tients (patients 1, 6, 12, 15, 16; Tables I and 2). The
initial and follow-up specimens from 2 of the 14 pa-
tients did not contain free antibody reactive with
the infecting bacteria (patients 3, 9; Table 1). Free
antibody, when found, could be detected for only
relatively short periods of time after the infection
subsided; this time varied with each patient, ranging
from 2 to 15 weeks; thus, the antibody was undetec-
table after the 4th month.
To determine the specificity of the unbound anti-
body in the urine, specimens from 4 patients were
incubated with subcultures of homologous and het-
erologous bacteria. Reactive antibody was detected
by indirect immunofluorescence (Table 3). Urine
specimens from patient A contained antibody which
reacted only with the homologous infecting orga-
nism, Pseudomonas aeruginosa. Antibody in the
urine specimen from patient B reacted weakly with
three heterologous isolates from patients A, C, and
D, and the homologous Proteus mirabilis. Urine
specimens from patients C and D reacted not only
with the homologous Serratia marcescens and E.
co/i but also reacted weakly with all the heterolo-
gous bacteria tested.
Discussion
Multiple urine specimens from 24 patients (16
with pyelonephritis and 8 with cystitis) were tested
over a period of months to determine whether the
results of the FA tests for antibody-coated bacteria
can be expected to change with persistent or recur-
rent infections. The FA test results remained posi-
tive for 8 patients with persisting pyelonephritis
caused by the same bacterial strain. We interpreted
this to mean that there was a continuing synthesis of
antibody during the infection (Table 1, A).
The results of the FA tests were also positive for
4 patients with renal parenchymal infections which
eventually cleared with therapy but recurred
(caused by the same bacteria) within 2 months after
cessation of treatment (Table 1, B). There are at
least three possible explanations: (1) as postulated
by Turck, Ronald, and Petersdorf [11], the recur-
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Table 3. Results of indirect FA tests on urine supernatants from four patients with renal infection to detect the presence of antibody
against homologous bacteria and cross-reactive antibody against heterologous bacteriaa
Test bacteria




trotA B C D
I. Patients' own isolates
Pseudomonas aeruginosa (A) +b Neg
Proteus mirabilis (B) Neg + Neg
Serratia marcescens (C) Neg Neg
E. coil (D) Neg Neg
II. Other urinary tract pathogens
K!ebsiellapneumoniae (E) Neg Neg + + Neg
Enterobacter aerogenes (F) Neg Neg + + Neg
Streptococcus faecalis (0) Neg Neg Neg
Staphylococcus aureus (H) Neg Neg Neg
Four urine specimens positive for antibody-coated bacteria as determined by the direci FA test were centrifuged; supernatants were
tested by the indirect FA test for presence of antibody reactive with subcultures of the patients' own bacterial isolates (A—D) and isolates
from other patients (E—H); urines A, D, and isolates A, D, E were from patients 6, 10, and 1, respectively (Table 1); the other urines B, C,
and isolates B, C, F, 0, H were from other patients without persisting or recurring infections or patients who were not available for clinic
follow-up after their initial episodes of infection.
bApproximately 100% of bacterial cells in every microscopic field (x 50 oil objective) fluoresced with the intensity of +.
rence could be a relapse due to bacteria that sur-
vived in the renal parenchymal tissue through the
course of therapy—presumably, specific antibody-
continued to be synthesized, coating the reemerging
bacteria; (2) the recurrence could be a newly estab-
lished ascending infection—newly synthesized spe-
cific antibody or antibody from the previous kidney
infection coated the invading bacteria; and (3) the
recurrence could be a newly established infection
confined to the bladder—however, because anti-
body was still being synthesized as the result of a
recently eradicated kidney infection, the invading
bacteria became coated, giving a "false-positive"
FA test. Although direct localization studies were
not possible on each of the 4 patients, results for 1
were available: bilateral ureteral catheterizations of
patient 11 (Table I, B) showed that the antibody-
coated Citrobacter diversus, causing the recur-
rence, originated from the left kidney.
Recurrent infections with bacteria different from
the initial infecting strains occurred in 5 patients
(patient 12, Table 1, B; patients 13, 14, 15, 16, Table
2) whose infections had cleared with therapy. FA
tests were positive for 14 of the 27 reinfection epi-
sodes; tests on follow-up specimens continued to be
FA-positive. These results suggest that renal infec-
tion frequently recurs in patients with previously
documented parenchymal infection. Further evi-
dence for this was the finding that 5 of 13 initially
FA-negative episodes were associated with con-
version from negative to positive FA test results
when the infection persisted. We believe that the
FA conversions were due to ascendence of infec-
tion; two direct localization studies during separate
reinfections in one of the patients (patient 15, Table
2) indicated that the bacteria causing these reinfec-
tions came from the kidney. In addition, these data
suggest that in pyelonephritis, "reinfections" occur
much more frequently than "relapse" infections,
even when anatomical or metabolic abnormalities
are present (as noted in Tables 1 and 2); other inves-
tigators have reported similar findings [12, 13].
In contrast to patients with renal infections, FA
tests remained negative on all specimens from pa-
tients with recurrent cystitis, whether the infection
involved the same or a different bacterial strain.
The negative test results indicated a failure of the
antigens of the bacterial surface to elicit an immune
response. This could be due to a lack of tissue in-
vasion and, therefore, a lack of stimulation of anti-
body-forming cells. The length of time during which
a patient with cystitis is exposed to bacterial anti-
gens may be of importance in determining whether
a local immune response is elicited. A patient with
acute symptoms of cystitis usually seeks treatment
soon after the onset of symptoms. Specific therapy
destroys the bacteria, thus shortening the exposure
to the immunogen. This explanation may also hold
for cases of acute pyelonephritis that are associated
with negative FA test results (2, 5, 14]; our previous
observation of "false-negative" results in 20%
(3/15) of the obstetrical patients with acute pyelone-
phritis [2] led us to a conclusion that the duration of
exposure was too brief—the patient developed
acute symptoms and was treated before an immune
response had occurred. Perhaps patients with cys-
titis would respond immunologically if the infection
were chronic or involved the deeper layers of the
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bladder wall. This study did not include patients
with persisting cystitis, but three of the patients had
recurrent cystitis caused by the same bacteria; the
FA test continued to be negative even though the
patients were exposed intermittently to the same
bacterial strain, in one case for as long as 143 days.
The indirect FA studies showed that urine super-
natants from patients with renal infections often
contained excess antibody; this antibody was reac-
tive with subcultures of the patients' own infecting
bacteria. Tests on the initial specimens showed that
7 of 14 patients with renal infections had urine spec-
imens containing free antibody reactive with the ho-
mologous infecting bacteria. Within 4 months, the
antibody became detectable in the follow-up speci-
mens from 5 of the other 7 patients. Free urinary
antibody was detectable in these 12 patients, some-
times for months in the course of persistent infec-
tion with the same bacterial strain. Once the infec-
tion subsided with therapy, however, the antibody
became undetectable in the course of 4 months.
Whether the short-lived antibody can protect
against recurrences of ascending infection with the
homologous organism or other antigenically related
organisms remains to be determined. Excess anti-
body was not found in urine specimens from 2 of the
14 patients.
Urine specimens from 4 patients with renal infec-
tions were tested by the indirect FA method for
antibody reactive with homologous and heterolo-
gous bacteria (Table 3). Each urine specimen con-
tained antibody reactive with that patient's own iso-
late. Urine from patient A contained antibody that
reacted only with the homologous isolate Pseudo-
monas aeruginosa. The urine specimen from pa-
tient B contained antibody that reacted not only
with the homologous bacteria (B) but also reacted,
even though less intensely, with three of the heter-
ologous bacteria (A, C, and D). Urine specimens
from patients C and D contained antibody reactive
with the homologous bacteria, as well as all of the
heterologous bacteria. The weak fluorescence ob-
served with the heterologous bacteria was probably
due to the cross reactivity of urinary antibody with
various antigens. Since the free antibody may be
present in the urine for as long as 4 months, possi-
bly longer, this could cause "false-positive" FA
test results; for example, antibody from a previous
kidney infection may coat the bacteria of a newly
established bladder infection simply because the
antibody is cross-reactive. We do not yet know how
often such "false-positive" results occur.
Proteinuna may be another potential source of
false-positive tests which would influence the deci-
sion as to the site of urinary tract infection. In two
reported studies [15, 16], a total of ten urine speci-
mens from eight proteinuric patients without infec-
tion were tested by indirect immunofluorescence.
The specimens were tested for antibody against a
battery of different bacteria isolated from other pa-
tients with urinary tract infections; 21 (30%) of the
71 tests were positive. In an earlier study [17], we
tested urine specimens from proteinuric patients
with urinary infection and found that abnormally
elevated levels of total urinary protein, IgG, IgA,
and 1gM were not always associated with positive
direct FA tests. Urine specimens from most pa-
tients with renal infections, characterized by the
presence of antibody-coated bacteria, had normal
levels of urinary protein and immunoglobulins.
Thus, although the vast majority of positive tests
are not associated with abnormal proteinuria, these
observations suggest caution when interpreting pos-
itive FA results on specimens from proteinuric pa-
tients to mean kidney infection.
Reading the results of FA tests as immuno-
fluorescence-positive or -negative deserves com-
ment because published studies have used different
criteria. We interpret an FA test as negative when
less than 25% of the organisms in each microscopic
field are fluorescing. This strict criterion was
adopted because occasionally small numbers of flu-
orescing bacteria may be observed in urine speci-
mens from uninfected controls. We found that anti-
body-coated bacteria are frequently present in the
vaginal vestibule flora of patients without urinary
tract infections. Other investigators have also made
this observation [9, 18]. A false-positive test may be
due to contamination of voided urine with antibody-
coated bacteria and yeast from the vagina and vagi-
nal vestibule. The possibility of such contamination
would be a major problem if the criterion for a posi-
tive FA test were as low as 2 fluorescing bacteria
per 200 microscopic fields, as has been suggested by
others [19]. This problem can best be controlled by
testing only clean-catch midstream urine specimens
that have been stored at 40 C until tested, and read-
ing the test results as positive when at least 25% of
the bacteria are fluorescing. In our experience,
specimens containing small numbers of fluorescing
bacteria are uncommon; in a positive test the vast
majority of the bacteria in each field usually fluo-
resce. When less than 25% of the bacteria fluoresce,
repeated collections and examinations will usually
clarify the interpretation of the results as either pos-
itive or negative.
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The opportunity of examining a group of patients
over a period of years has provided information on
the usefulness of the FA test in the evaluation of
persistent and recurrent urinary tract infections.
The finding of a positive FA test, particularly in the
absence of new signs and symptoms of disease,
alerts the physician that invasion of renal tissue has
occurred; the kidney may have been invaded for the
first time or still another time. The physician is then
capable of initiating further diagnostic tests for un-
derlying metabolic or structural abnormalities
which are often associated with renal parenchymal
infection. Initial reports indicate that the FA test for
detecting the presence or absence of antibody-
coated bacteria in urine sediment may also be useful
in determining the dose and duration of antibiotic
therapy [20, 21].
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